KRTAP1-4 inhibitors are a class of chemical compounds that target the Keratin-associated proteins (KRTAP), particularly the subfamily members KRTAP1 through KRTAP4. These proteins are involved in the regulation of keratin intermediate filament organization, which plays a key role in maintaining the structural integrity of epithelial cells. Inhibitors of KRTAP1-4 typically function by disrupting the molecular interactions between keratins and their associated proteins, leading to alterations in the dynamics of keratin filament assembly. The structural diversity of these inhibitors can range from small molecules to peptides, with specific binding affinities for the KRTAP1-4 subfamily. This specificity is largely attributed to the unique binding motifs and conformations present within these proteins, allowing for selective inhibition that minimizes off-target interactions with other keratin-associated proteins.
Mechanistically, KRTAP1-4 inhibitors act by influencing the phosphorylation state, protein-protein interactions, or post-translational modifications of keratin filaments. These effects lead to modifications in the cytoskeletal architecture, potentially altering cellular processes such as migration, adhesion, and differentiation. The precise molecular targets of these inhibitors can vary, depending on the structural features of the compound and the specific KRTAP family member it targets. In biochemical studies, KRTAP1-4 inhibitors are often employed to investigate the regulatory pathways governing keratin network organization, as well as to study the role of these proteins in cellular resilience to mechanical stress. Understanding the molecular basis of KRTAP1-4 inhibition is critical for dissecting the complexities of keratin function and the broader cytoskeletal systems in which they are embedded.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits eukaryotic protein synthesis, potentially reducing KRTAP1-4 levels. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Prevents proteasomal degradation, which can influence KRTAP1-4 stability. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interferes with DNA-dependent RNA synthesis, possibly affecting KRTAP1-4 transcription. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Causes premature termination of protein translation, possibly leading to reduced KRTAP1-4 synthesis. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Inhibits lysosomal degradation, potentially affecting the turnover of KRTAP1-4. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can decrease protein synthesis, potentially lowering KRTAP1-4 levels. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Inhibits the proteasome, potentially increasing KRTAP1-4 levels due to reduced degradation. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Inhibits RNA polymerase II, potentially decreasing KRTAP1-4 mRNA production. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Inhibits histone deacetylases, potentially affecting KRTAP1-4 gene expression. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Binds to Hsp90, which can affect the folding and function of client proteins, including potentially KRTAP1-4. | ||||||